Avita Medical Limited

Feb 10, 2012

OVERVIEW | NEWS | MULTIMEDIA | RESEARCH

Avita Medical Limited Company Summary

Avita Medical Limited (ASX: AVH) is an ASX listed medical device company formed through the merger of Clinical Cell Culture Ltd and Visiomed Group Ltd in February 2008.

Following the merger Avita Medical is now active in the regenerative medicine and respiratory sectors and has three products in the market. For more information about Avita Medical please visit: http://www.avitamedical.com

COMPANY DATA

	Principal Sector	Health & Pharm

	Principal Industry	Biotechnology

	Homepage	www.avitamedical.com

Key Developments: Avita Medical Limited

	Australian Market Report of February 2, 2011: Fortis Mining (ASX:FMJ) Secures Strategic Hong Kong Investment And Partnership FEB 2, 2011 13:30 - Article Views: 2,255 Australian Market Report of February 2, 2011 includes: Fortis Mining Limited (ASX:FMJ) has entered into a strategic partnership alliance with Grand Concord Investments Limited; Peninsula Energy Limited (ASX:PEN) announced 33Mlbs U3O8 resources in USA; Molopo Energy Limited (ASX:MPO) is to sell Spearfish oil asset to Legacy Oil + Gas Inc (TSE:LEG); Avita Medical Limited (ASX:AVH) completed ISO quality certification audit to sell its products in Europe.

	Australian Market Report of May 31, 2010: Avita Medical (ASX:AVH) Advances Marketing in China and Taiwan MAY 31, 2010 13:30 - Article Views: 4,087 The Australian shares opened slightly lower this morning with weak overseas lead. Fitch Ratings has downgraded Spain's credit rating from AAA to AA-plus, saying the country's economic recovery will be more muted than the government forecast. The local market is under pressure after the downgrade fuelled concerns over the Eurozone crisis.

	World's Largest Adidas Store To Open In Beijing JULY 3, 2008 22:03 - Article Views: 5,645 adidas AG New adidas Brand Center concept offers products from all adidas categories under one roof, taking the adidas retail experience to a new level

	Helicon Group Limited (ASX:HCG) Secures Milestone Regulatory Approval In China For Skin Regeneration Medical Technology ReCell(R) JULY 3, 2008 12:32 - Article Views: 3,946 HELICON GROUP LIMITED (ASX:HCG) today announced that the Chinese State Food and Drug Administration (SFDA) has granted approval for the skin regeneration concept and device, ReCell(R).